On June 24, 2025, Protagenic Therapeutics, Inc. announced a rights distribution for stockholders to purchase additional shares following their acquisition of Phytanix. Stockholders of record as of July 7, 2025, can buy 4.57 shares at $0.01 each, pending approval at a stockholder meeting.